News
Dishman Pharmaceuticals and Chemicals Ltd <DISH.BO> said on Friday its Naroda plant near Ahmedabad has received US FDA approval for producing active pharmaceutical ingredients (API) meant for the ...
Sources said that contract research and manufacturing player Dishman Pharmaceuticals & Chemicals Ltd is close to clinch one more acquisition deal in Switzerland. AHMEDABAD: Gujarat CM Narendra ...
AHMEDABAD: Following a search-and-survey operation on Dishman Carbogen Amcis Ltd earlier this month, the state income tax (I-T) department has claimed to have found a trail of unaccounted for cash ...
Dishman Get EIR: Drug firm Dishman Pharmaceuticals and Chemicals Ltd has received Establishment Inspection Report (EIR) from the US health regulator on closure of inspection of its Bavla facility ...
Ahmedabad-based Dishman Pharmaceuticals and Chemicals Ltd today said it will acquire the pharmaceutical services business of US-based Solutia Inc for 74.5 million dollars.
Dishman Pharmaceuticals and Chemicals Ltd said on Thursday said it has increased its stake in a local joint venture with a German partner to 72.33 per cent from 22.33 per cent for €300,000 (about $341 ...
Fire At Dishman Pharma: Drug firm Dishman Pharmaceuticals and Chemicals Ltd today said there was fire at one of the units of its Bavla facility on Tuesday evening.
Dishman Pharmaceuticals and Chemicals Limited has received SEBI acknowledgement for its proposed IPO of 3,433,400 equity shares of Rs.10 each. The issue would be through 100 per cent book building ...
Dishman Pharmaceuticals has received the Establishment Inspection Report (EIR) from the US FDA for Bavla facility on February 01, 2017. Thus, the Company’s facilities in Bavla, Naroda and ...
Dishman Pharma: A healthy contract Growth prospects for this CRAMS player seem robust By Nalinakanthi V. Updated - January 16, 2018 at 06:33 PM. PO10_pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results